Letter: Hyperpigmentation after cancer chemotherapy.
D000293:Adolescent; D002648:Child; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005385:Fingers; D006801:Humans; D008297:Male; D009262:Nails; D009404:Nephrotic Syndrome / Q000188:drug therapy; D010859:Pigmentation Disorders / Q000139:chemically induced*
D003520:Cyclophosphamide